Faeth Therapeutics, Inc. Common Stock FTH

$12.68 -42.49% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-11-09 View →
8-K 8-K 2026-11-09 View →
4 Insider transaction 2026-11-03 View →
8-K 8-K 2026-11-03 View →
10-Q 10-Q 2026-11-03 View →
4 Insider transaction 2026-10-27 View →
8-K 8-K 2026-10-27 View →
8-K 8-K 2026-09-17 View →
4 Insider transaction 2026-09-15 View →
10-Q 10-Q 2026-08-04 View →
8-K 8-K 2026-08-04 View →
8-K 8-K 2026-07-23 View →
4 Insider transaction 2026-07-23 View →
4 Insider transaction 2026-07-23 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-06-26 View →
4 Insider transaction 2026-06-24 View →
4 Insider transaction 2026-06-24 View →
8-K 8-K 2026-06-18 View →
4 Insider transaction 2026-06-16 View →
4 Insider transaction 2026-06-16 View →
4 Insider transaction 2026-06-16 View →
8-K 8-K 2026-06-15 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
8-K 8-K 2026-06-10 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
8-K 8-K 2026-05-22 View →
8-K 8-K 2026-05-21 View →
4 OWNERSHIP DOCUMENT 2026-05-15 View →
4 OWNERSHIP DOCUMENT 2026-05-15 View →
4 OWNERSHIP DOCUMENT 2026-05-15 View →
10-Q 10-Q 2026-05-15 View →
8-K 8-K 2026-05-15 View →
S-3 S-3 2026-04-28 View →
DEF 14A DEF 14A 2026-04-27 View →
8-K 8-K 2026-04-16 View →
4 Insider transaction 2026-04-14 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$12.68
Market Cap
$569.86 million
52-Week Range
$10.45 – $42.14
Average Volume
477K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.